Clinical Trials
16
Active:3
Completed:9
Trial Phases
2 Phases
Phase 4:2
Not Applicable:12
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Not Applicable
12 (85.7%)Phase 4
2 (14.3%)TCRM for Correction of Cheek Including Fine Lines
Not Applicable
Active, not recruiting
- Conditions
- Skin AgingCheek Wrinkles
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Teoxane SA
- Target Recruit Count
- 130
- Registration Number
- NCT07145905
- Locations
- 🇪🇸
Centro Médico Lajo Rosso, Madrid, Spain
TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults
Not Applicable
Recruiting
- Conditions
- Infraorbital Hollows
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Teoxane SA
- Target Recruit Count
- 260
- Registration Number
- NCT06749587
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, China
RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)
Not Applicable
Active, not recruiting
- Conditions
- AgingPain
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Teoxane SA
- Target Recruit Count
- 20
- Registration Number
- NCT06378086
- Locations
- 🇺🇸
United States, Birmingham, Alabama, United States
🇵🇷Puerto Rico, San Juan, Puerto Rico
🇺🇸United States, New York, New York, New York, United States
TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults
Not Applicable
Recruiting
- Conditions
- Nasolabial Folds
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Teoxane SA
- Target Recruit Count
- 390
- Registration Number
- NCT06367634
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, China
Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face
Not Applicable
Active, not recruiting
- Conditions
- Chin RetrusionAging
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Teoxane SA
- Target Recruit Count
- 155
- Registration Number
- NCT05986630
- Locations
- 🇨🇭
Care- Geneva, Geneva, Switzerland
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found